Expert Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of bioactive ingredients from traditional Chinese medicine for controlled release which introduced me to biomaterials and drug delivery systems
CPHI Americas 2026: Where Strategic Partnerships, AI, and Advanced Manufacturing Are Shaping Pharma’s Future
CPHI Americas marks a fundamental shift in what a pharmaceutical industry event can be Weve moved toward a contentfirst experience that prioritises strategic learning and meaningful connections
Leadership Insights: 6thAnnual Rare & Genetic Kidney Disease Drug Development Summit
The most important shift I have seen is the move from phenotypefirst to genotypefirst thinking and that is changing everything from diagnosis to trial design Genetic testing is moving earlier in the workup particularly
Pharmacovigilance in the GLP-1 Era: Safety Surveillance Challenges for Obesity Medicines and Real-World Use
The rapid uptake of GLP therapies is pushing pharmacovigilance beyond traditional slower models built for smaller and more controlled treatment populations Obesity use is broader longerterm
From Clinical Trials to Pharmacovigilance: A Multi-Agent Future
The industry has automated within silos not across them Your clinical data management systems dont communicate with safety databases Trial monitoring operates independently from postmarket surveillance
The Quiet Disciplines of High-Performance Labs: Talent, Modalities, and the Data-Native Future
In smallmolecule work a competent team can be built by hiring for HPLC method validation and impurity characterisation The playbook is established the regulatory pathway familiar and most midcareer scientists can slot in and deliver
Building the Bridge: How B2B Media Is Shaping the Future of Chemical Engineering
The shift is already well underway BB medias value used to be measured in reach how many engineers received your magazine how many clicks your digital content generated What downstream companies
GLP-1 Therapies in Real-World Weight Care: Provider Insights on Adoption, Adherence, and Outcomes
Before GLPs obesity management was neglected There was no real plan or employer focus on obesity GLPs have completely changed that For good and bad never has a drug been demanded by consumers like this The good thing is that there now is a focus on obesity and the upside of treating it properly in terms of improved cardiometabolic outcomes
Single Use Technologies (SUT) in Pharmaceutical Manufacturing
SUT has shifted manufacturing toward speed flexibility and modular capacity By replacing fixed stainless steel
Fundamentals and Design of Drug Delivery Systems
A Textbook with Lab Activities
Most engineering students lack foundational pharmacology knowledge yet advanced drug delivery system design must be
